top of page

News

5 days ago

MitoSense and University of Pittsburgh Sign MOU to Explore Mitochondrial Research for Space Biomedicine and Long COVID

Apr 20

Renowned Physician and Longevity Expert Dr. Robert Lufkin Highlights MitoSense’s MOT™ Technology

Mar 5

MitoSense Congratulates Greenwood Genetic Center on $1.1 Million in Federal Alzheimer’s Funding and New Genetic Study Demonstrating Mitochondrial Restoration

Feb 6

MitoSense Sponsors Countdown For A Cure and Celebrates CFAC’s Annual Event

Jul 30, 2025

MitoSense to Attend MHSRS, August 4 -7, 2025

Jun 27, 2025

MitoSense's Collaboration with the VA and WRAIR Highlighted in House Hearing with HHS Secretary RFK, Jr.

Apr 30, 2025

MitoSense’s MOT™ Technology Featured In Newsmax Article Highlighting Secretary Kennedy’s Vision To Tackle Mitochondria Dysfunction To Fight Chronic Disease

MitoSense’s MOT™ technology was featured in a recent Newsmax article. The article highlights how U.S. Department of Health and Human...

Feb 3, 2025

MitoSense Secures Japanese Patent for Groundbreaking Mitochondria-Based Therapy for Neurodegenerative Diseases

February 4, 2025 – Plymouth, MA – MitoSense Inc., a pioneering biotechnology company specializing in mitochondria-based therapeutics, is...

bottom of page